Influence of Cytokines on Inflammatory Eye Diseases: A Citation Network Study

Overview

Journal J Clin Med

Specialty General Medicine

Date 2022 Feb 15

PMID 35160111

Authors

Beatriz G Galvez

Clara Martinez-Perez

Cesar Villa-Collar

Cristina Alvarez-Peregrina

Miguel Angel Sanchez-Tena

Affiliations

Soon will be listed here.

Abstract

Background: The main objective of this study was to use citation networks to analyze the relationship between different publications on the impact of cytokines at an ocular level and their authors. Furthermore, the different research areas will be identified, and the most cited publications determined.

Methods: A search was performed in the Web of Science (WoS) database using the following keywords: "cytokine", "inflammatory", and "eye disease" for the period from 1990 to October 2021. The Citation Network Explorer and the CiteSpace software were then used to analyze the different publications.

Results: 3127 publications with 8955 citations generated on the web were found. The largest number of publications on this topic emerged in 2018 and the authors with the largest number of publications addressing this area of research were Peizeng Yang (1.4%), Aize Kijlstra (1.3%), and Stephen C. Pflugfelder (1.2%).

Conclusions: the citation network has provided a comprehensive and objective analysis of the main studies on the influence of cytokines in ocular inflammatory diseases.

Citing Articles

Tear-Based Ocular Wearable Biosensors for Human Health Monitoring.

Rajan A, Vishnu J, Shankar B Biosensors (Basel). 2024; 14(10).

PMID: 39451696 PMC: 11506517. DOI: 10.3390/bios14100483.

Experiment-based computational model predicts that IL-6 classic and trans-signaling exhibit similar potency in inducing downstream signaling in endothelial cells.

Song M, Wang Y, Annex B, Popel A NPJ Syst Biol Appl. 2023; 9(1):45.

PMID: 37735165 PMC: 10514195. DOI: 10.1038/s41540-023-00308-2.

References

Amadi-Obi A, Yu C, Liu X, Mahdi R, Clarke G, Nussenblatt R . TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1. Nat Med. 2007; 13(6):711-8. DOI: 10.1038/nm1585. View

Vasan R, Sullivan L, Roubenoff R, Dinarello C, Harris T, Benjamin E . Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction: the Framingham Heart Study. Circulation. 2003; 107(11):1486-91. DOI: 10.1161/01.cir.0000057810.48709.f6. View

Xu H, Chen M, Forrester J . Para-inflammation in the aging retina. Prog Retin Eye Res. 2009; 28(5):348-68. DOI: 10.1016/j.preteyeres.2009.06.001. View

Rosenbaum J, Boney R . Use of a soluble interleukin-1 receptor to inhibit ocular inflammation. Curr Eye Res. 1991; 10(12):1137-9. DOI: 10.3109/02713689109024131. View

Abidi A, Shukla P, Ahmad A . Lifitegrast: A novel drug for treatment of dry eye disease. J Pharmacol Pharmacother. 2017; 7(4):194-198. PMC: 5242036. DOI: 10.4103/0976-500X.195920. View

Stern M, Beuerman R, Fox R, Gao J, Mircheff A, Pflugfelder S . The pathology of dry eye: the interaction between the ocular surface and lacrimal glands. Cornea. 1998; 17(6):584-9. DOI: 10.1097/00003226-199811000-00002. View

Aparicio-Martinez P, Perea-Moreno A, Martinez-Jimenez M, Redel-Macias M, Vaquero-Abellan M, Pagliari C . A Bibliometric Analysis of the Health Field Regarding Social Networks and Young People. Int J Environ Res Public Health. 2019; 16(20). PMC: 6843989. DOI: 10.3390/ijerph16204024. View

Enriquez-de-Salamanca A, Castellanos E, Stern M, Fernandez I, Carreno E, Garcia-Vazquez C . Tear cytokine and chemokine analysis and clinical correlations in evaporative-type dry eye disease. Mol Vis. 2010; 16:862-73. PMC: 2874579. View

Cai X, Zhou C, Zhou L, Xu Q . A bibliometric analysis of IL-35 research from 2009 to 2018. PeerJ. 2019; 7:e7992. PMC: 6825408. DOI: 10.7717/peerj.7992. View

10.

Martinez-Perez C, Alvarez-Peregrina C, Villa-Collar C, Sanchez-Tena M . Citation Network Analysis of the Novel Coronavirus Disease 2019 (COVID-19). Int J Environ Res Public Health. 2020; 17(20). PMC: 7593954. DOI: 10.3390/ijerph17207690. View

11.

Elia G, Fallahi P, Ragusa F, Paparo S, Mazzi V, Benvenga S . Precision Medicine in Graves' Disease and Ophthalmopathy. Front Pharmacol. 2021; 12:754386. PMC: 8581657. DOI: 10.3389/fphar.2021.754386. View

12.

Pflugfelder S, de Paiva C . The Pathophysiology of Dry Eye Disease: What We Know and Future Directions for Research. Ophthalmology. 2017; 124(11S):S4-S13. PMC: 5657523. DOI: 10.1016/j.ophtha.2017.07.010. View

13.

Felfeli T, Juncal V, Hillier R, Mak M, Wong D, Berger A . Aqueous Humor Cytokines and Long-Term Response to Anti-Vascular Endothelial Growth Factor Therapy in Diabetic Macular Edema. Am J Ophthalmol. 2019; 206:176-183. DOI: 10.1016/j.ajo.2019.04.002. View

14.

COOK E, Stahl J, Lowe L, Chen R, Morgan E, Wilson J . Simultaneous measurement of six cytokines in a single sample of human tears using microparticle-based flow cytometry: allergics vs. non-allergics. J Immunol Methods. 2001; 254(1-2):109-18. DOI: 10.1016/s0022-1759(01)00407-0. View

15.

Kern T . Contributions of inflammatory processes to the development of the early stages of diabetic retinopathy. Exp Diabetes Res. 2008; 2007:95103. PMC: 2216058. DOI: 10.1155/2007/95103. View

16.

Messmer E . The pathophysiology, diagnosis, and treatment of dry eye disease. Dtsch Arztebl Int. 2015; 112(5):71-81. PMC: 4335585. DOI: 10.3238/arztebl.2015.0071. View

17.

SanGiovanni J, Chew E . The role of omega-3 long-chain polyunsaturated fatty acids in health and disease of the retina. Prog Retin Eye Res. 2004; 24(1):87-138. DOI: 10.1016/j.preteyeres.2004.06.002. View

18.

Pflugfelder S, Jones D, Ji Z, Afonso A, Monroy D . Altered cytokine balance in the tear fluid and conjunctiva of patients with Sjögren's syndrome keratoconjunctivitis sicca. Curr Eye Res. 1999; 19(3):201-11. DOI: 10.1076/ceyr.19.3.201.5309. View

19.

Liddelow S, Guttenplan K, Clarke L, Bennett F, Bohlen C, Schirmer L . Neurotoxic reactive astrocytes are induced by activated microglia. Nature. 2017; 541(7638):481-487. PMC: 5404890. DOI: 10.1038/nature21029. View

20.

Millan-Longo C, Peiteado D, Schlincker A, Hidalgo V, Pieren A, Balsa A . Use of Immunomodulatory Drugs at a Uveitis Clinic. Reumatol Clin (Engl Ed). 2017; 15(5):271-276. DOI: 10.1016/j.reuma.2017.09.008. View